semaglutide ban Fifth Circuit probes FDA on compounded GLP-1s Will Compounded Semaglutide Be Banned?

Identification of a candidate therapeutic autophagy-inducing peptide

Patients may need help deciding whether medication is appropriate, managing side effects, protecting muscle, setting realistic goals, reviewing progress, and planning for what happens if treatment changes

Among these participants, 48.7% achieved at least 20% weight reduction versus 3.1% on placebo

However, interpretation of these signatures may be confounded by kidney function and medication use, and clinical translation will require rigorous external validation, particularly in prospective cohorts and trials specifically designed for DKD

Weight loss medications and fat burning pills are vastly different

Funk OG, Yung R, Arrighi S, Lee S